ZIMLUCIO Trademark

Trademark Overview

On Wednesday, December 18, 2019, a trademark application was filed for ZIMLUCIO with the United States Patent and Trademark Office. The USPTO has given the ZIMLUCIO trademark a serial number of 79278456. The federal status of this trademark filing is REGISTERED as of Tuesday, January 12, 2021. This trademark is owned by STADA Arzneimittel AG. The ZIMLUCIO trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical preparations and biologic medicines used in the treatment of angiogenesis and ocular diseases and disorders as well as angiogenesis and ocular conditions related to diabetic, oncological, macular and vascular diseases and disorders; dietetic food adapted for medical use; dietary supplements for humans

Applicators in the nature of droppers and syringes for administering medications into the human eye, sold empty; medical apparatus for introducing pharmaceutical preparations into the human body; diagnostic apparatus for detecting angiogenesis and ocular diseases and disorders for medical purposes
zimlucio

General Information

Serial Number79278456
Word MarkZIMLUCIO
Filing DateWednesday, December 18, 2019
Status700 - REGISTERED
Status DateTuesday, January 12, 2021
Registration Number6242115
Registration DateTuesday, January 12, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 27, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations and biologic medicines used in the treatment of angiogenesis and ocular diseases and disorders as well as angiogenesis and ocular conditions related to diabetic, oncological, macular and vascular diseases and disorders; dietetic food adapted for medical use; dietary supplements for humans
Goods and ServicesApplicators in the nature of droppers and syringes for administering medications into the human eye, sold empty; medical apparatus for introducing pharmaceutical preparations into the human body; diagnostic apparatus for detecting angiogenesis and ocular diseases and disorders for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 14, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, February 14, 2020
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSTADA Arzneimittel AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameSTADA Arzneimittel AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameSTADA Arzneimittel AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Friday, June 4, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, May 11, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, April 20, 2021FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, April 20, 2021FINAL DISPOSITION PROCESSED
Monday, April 12, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 12, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, October 27, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 27, 2020PUBLISHED FOR OPPOSITION
Sunday, October 25, 2020NOTIFICATION PROCESSED BY IB
Monday, October 19, 2020LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Wednesday, October 7, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 7, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 7, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 23, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 23, 2020EXAMINER'S AMENDMENT ENTERED
Wednesday, September 23, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, September 23, 2020EXAMINERS AMENDMENT E-MAILED
Wednesday, September 23, 2020EXAMINERS AMENDMENT -WRITTEN
Friday, September 18, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 18, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 18, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 27, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, July 27, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 27, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, July 27, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 27, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 27, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, May 22, 2020LIMITATION OF GOODS RECEIVED FROM IB
Friday, April 10, 2020REFUSAL PROCESSED BY IB
Tuesday, March 24, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, March 24, 2020REFUSAL PROCESSED BY MPU
Wednesday, March 4, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, March 3, 2020NON-FINAL ACTION WRITTEN
Monday, March 2, 2020ASSIGNED TO EXAMINER
Tuesday, February 18, 2020APPLICATION FILING RECEIPT MAILED
Friday, February 14, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 13, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

zimlucio disorders ocular angiogenesis medical diseases human pharmaceutical apparatus preparations droppers